We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

79 hedge funds and large institutions have $68.9M invested in Immunomedics Inc in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 24

8% less call options, than puts

Call options by funds: $2.72M | Put options by funds: $2.96M

7% less funds holding

Funds holding: 85 → 79 (-6)

28% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 18

58% less capital invested

Capital invested by funds: $166M → $68.9M (-$97.1M)

Holders
79
Holders Change
-6
Holders Change %
-7.06%
% of All Funds
2.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
27
Reduced
24
Closed
18
Calls
$2.72M
Puts
$2.96M
Net Calls
-$241K
Net Calls Change
-$2.48M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$8.48M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$5.12M
3
ACP
Acuta Capital Partners
California
+$4.37M
4
Goldman Sachs
Goldman Sachs
New York
+$713K
5
PAM
Panagora Asset Management
Massachusetts
+$535K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$10.2M
2
WCM Investment Management
WCM Investment Management
California
-$8.09M
3
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$6.09M
4
PA
Perceptive Advisors
New York
-$2.44M
5
CS
Candriam SCA
Luxembourg
-$1.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$24.4M +$445K +174,217 +1%
BFA
2
BlackRock Fund Advisors
California
$6.72M +$402K +157,491 +4%
O
3
OrbiMed
New York
$5.72M +$8.48M +3,323,000 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$5.71M +$287K +112,598 +4%
BIT
5
BlackRock Institutional Trust
California
$4.67M -$529K -207,362 -7%
Balyasny Asset Management
6
Balyasny Asset Management
Illinois
$3.45M +$5.12M +2,004,078 New
ACP
7
Acuta Capital Partners
California
$2.94M +$4.37M +1,711,067 New
State Street
8
State Street
Massachusetts
$2.24M -$34.7K -13,590 -1%
Northern Trust
9
Northern Trust
Illinois
$1.86M +$295K +115,667 +12%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$947K +$10.5K +4,107 +0.8%
TCIM
11
TIAA CREF Investment Management
New York
$758K +$23.6K +9,260 +2%
PAM
12
Panagora Asset Management
Massachusetts
$755K +$535K +209,638 +91%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$739K -$338K -132,576 -24%
Goldman Sachs
14
Goldman Sachs
New York
$612K +$713K +279,237 +364%
BIM
15
BlackRock Investment Management
Delaware
$577K -$18.9K -7,414 -2%
BCM
16
Bridgeway Capital Management
Texas
$497K +$168K +66,000 +30%
JPTCCM
17
J.P. Turner & Co Capital Management
Georgia
$428K +$893 +350 +0.1%
Charles Schwab
18
Charles Schwab
California
$412K +$109K +42,700 +22%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$370K -$15.9K -6,241 -3%
SW
20
SVB Wealth
Massachusetts
$335K – – –
TA
21
Teachers Advisors
New York
$304K +$47.3K +18,519 +12%
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$302K -$1.53K -600 -0.3%
Connor, Clark & Lunn Investment Management (CC&L)
23
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$268K +$12K +4,700 +3%
California Public Employees Retirement System
24
California Public Employees Retirement System
California
$257K – – –
Swiss National Bank
25
Swiss National Bank
Switzerland
$197K +$47.2K +18,500 +19%
1
2 3 4

IMMU Hedge Fund Activity: Q3 2015 in Review

79 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2015, worth a combined $68.9M — down 58% from $166M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of IMMU and 13 opened new positions — a net loss of 5 holders — while 24 trimmed existing stakes and 27 added.

The largest buyer was OrbiMed, opening a new position worth an estimated $8.48M. The largest seller was Deerfield Management, exiting entirely with an estimated $10.2M sold.

  • 79 institutional investors held Immunomedics Inc (IMMU) as of Q3 2015, down from 85 in Q2 2015.
  • Funds reported $68.9M of Immunomedics Inc stock for Q3 2015, down 58% quarter-over-quarter.
  • 13 funds opened new Immunomedics Inc positions in Q3 2015 and 18 closed out, a net change of -5 holders.
  • The largest Immunomedics Inc buyer in Q3 2015 was OrbiMed, an estimated $8.48M added.
  • The largest Immunomedics Inc seller in Q3 2015 was Deerfield Management, an estimated $10.2M sold.

Based on aggregated 13F filings for Q3 2015.